Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 414
Selected: 0
NCT IDTitle
NCT07237256Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib
NCT02511522Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases
NCT02459301A Dose-Ranging Study of IPH2201 in Patients With Gynecologic Malignancies
NCT01780623An Investigation of Light Therapy for Cancer-related Fatigue (The LITE Study)
NCT00188708Effect of Casodex on Tumour Hypoxia - Prostate Cancer
NCT03822897De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
NCT02773524A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer
NCT00115713Effects of Aerobic Exercise Versus Weight Training in Breast Cancer Survivors During Chemotherapy
NCT04257396Carbon-Fibre Accessory (CARA) for Supine Breast Positioning to Reduce Toxicity in Whole Breast Radiotherapy
NCT00002561Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease
NCT00003684Theophylline in Treating Cancer Patients With Shortness of Breath
NCT01815476The Prone Breast Radiation Therapy Trial
NCT03548636Project MOVE: Increasing Physical Activity Among Breast Cancer Survivors
NCT05371808Economic Analysis of Early vs Delayed Therapy in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma:
NCT03270995Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study
NCT02927249Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
NCT00258375OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer
NCT01396408A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
NCT05640999Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
NCT03057106Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC
NCT03271892Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer
NCT00054106Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer
NCT01479283Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY)
NCT00354302Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial
NCT00754845Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy
NCT00258388Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
NCT06630273Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics
NCT0193081218F-NaF PET Imaging for Bone Scintigraphy
NCT00471432OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
NCT01506687Increasing Colorectal Cancer Screening Uptake With a Patient Navigator
NCT00390169Randomized Controlled Trial Comparing MBSR to SET in Breast Cancer Patients
NCT06323707The IMPACT Implementation-Effectiveness Trial
NCT01152788Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent Melanoma
NCT05574426Efficacy of Movement Breaks in Real-World Settings
NCT00651326Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer
NCT00819208Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer
NCT01830621BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Pretreated Advanced Colorectal Carcinoma
NCT03624543CFI-400945 in Patients With Advanced/Metastatic Breast Cancer
NCT01147484A Study of Foretinib in Patients With Recurrent/Metastatic Breast Cancer
NCT03450018A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX
NCT00390117AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma
NCT02743741Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors
NCT03031821Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome
NCT07152821Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma
NCT03258554Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
NCT00064194Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia
NCT03108144Personalized Alerts and Care Pathways to Prompt Prevention Interventions for Alcohol and Tobacco Users in Primary Care
NCT00372736AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors
NCT00504296SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
NCT06915779Long Term Follow-up of HPV Vaccine in HIV (CTN 236)